Downloadable Slidesets

Share

Program Content

Activities

  • HR+/HER2- EBC Tx Benefit
    Prognostic and Predictive Measures of Therapeutic Benefit in Early Breast Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 15, 2021

    Expires: June 14, 2022

  • Adj Tx for HR+/HER2- EBC
    Adjuvant Therapy for Patients With HR+/HER2- EBC at High Risk of Recurrence
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 16, 2021

  • HR+/HER2- EBC Neoadj Tx
    Neoadjuvant Therapy Considerations With CDK4/6 Inhibitors in HR+/HER2- EBC
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 15, 2021

    Expires: June 14, 2022

  • <i>EP</i>: HR+/HER2- EBC
    ExpressPoints:
    Clinical Decision-Making for Patients With HR+ HER2- Early Breast Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 18, 2021

    Expires: June 17, 2022

Faculty

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Associate Director, Susan F. Smith Center for Women’s Cancers
Senior Physician, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Lilly